CII Telangana CEO’s Round Table on Policy and Advocacy Discussion Pharma Service
Biosecurity threats and business as usual
Three Indian CDMOs ready to seize the BIOSECURE Act opportunity
Home and US CAPEX places India on brink of bioCDMO breakthrough
Automation is critical to improve operational efficiency & accelerate innovation
Aragen’s Formulation Manufacturing Facility Achieves GMP Certification
Aragen’s Validation Journey with Getinge’s SUPR Single-Use Bioreactors
Contract Manufacturing: Pharma’s New Growth Pill
India CDMOs See Increased Interest Amid Global Manufacturing Turbulence
Aragen, a leading Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, has operationalized the first phase of its biologics manufacturing facility in Bangalore, India through its 100% subsidiary, Aragen Biologics Pvt Ltd.